Literature DB >> 26781991

NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells.

Jung Hee Joo1, Hyunjin Oh1, Myungjin Kim2, Eun Jung An1, Rae-Kwon Kim3, So-Young Lee1, Dong Hoon Kang1, Sang Won Kang1, Cheol Keun Park4, Hoguen Kim4, Su-Jae Lee3, Daekee Lee5, Jae Hong Seol6, Yun Soo Bae5.   

Abstract

The generation of reactive oxygen species (ROS) is required for proper cell signaling, but must be tightly regulated to minimize deleterious oxidizing effects. Activation of the NADPH oxidases (Nox) triggers ROS production and, thus, regulatory mechanisms exist to properly control Nox activity. In this study, we report a novel mechanism in which Nox1 activity is regulated through the proteasomal degradation of Nox organizer 1 (NoxO1). We found that through the interaction between NoxO1 and growth receptor-bound protein 2 (Grb2), the Casitas B-lineage lymphoma (Cbl) E3 ligase was recruited, leading to decreased NoxO1 stability and a subsequent reduction in ROS generation upon epidermal growth factor (EGF) stimulation. Additionally, we show that EGF-mediated phosphorylation of NoxO1 induced its release from Grb2 and facilitated its association with Nox activator 1 (NoxA1) to stimulate ROS production. Consistently, overexpression of Grb2 resulted in decreased Nox1 activity, whereas knockdown of Grb2 led to increased Nox1 activity in response to EGF. CRISPR/Cas9-mediated NoxO1 knockout in human colon cancer cells abrogated anchorage-independent growth on soft agar and tumor-forming ability in athymic nude mice. Moreover, the expression and stability of NoxO1 were significantly increased in human colon cancer tissues compared with normal colon. Taken together, these results support a model whereby Nox1 activity and ROS generation are regulated by Grb2/Cbl-mediated proteolysis of NoxO1 in response to EGF, providing new insight into the processes by which excessive ROS production may promote oncogenic signaling to drive colorectal tumorigenesis. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26781991     DOI: 10.1158/0008-5472.CAN-15-1512

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells.

Authors:  Shinan Li; Pham Ngoc Khoi; Hong Yin; Dhiraj Kumar Sah; Nam-Ho Kim; Sen Lian; Young-Do Jung
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD.

Authors:  Michael Seimetz; Natascha Sommer; Mariola Bednorz; Oleg Pak; Christine Veith; Stefan Hadzic; Marija Gredic; Nirmal Parajuli; Baktybek Kojonazarov; Simone Kraut; Jochen Wilhelm; Fenja Knoepp; Ingrid Henneke; Alexandra Pichl; Zeki I Kanbagli; Susan Scheibe; Athanasios Fysikopoulos; Cheng-Yu Wu; Walter Klepetko; Peter Jaksch; Christina Eichstaedt; Ekkehard Grünig; Katrin Hinderhofer; Miklós Geiszt; Niklas Müller; Flavia Rezende; Giulia Buchmann; Ilka Wittig; Matthias Hecker; Andreas Hecker; Winfried Padberg; Peter Dorfmüller; Stefan Gattenlöhner; Claus F Vogelmeier; Andreas Günther; Srikanth Karnati; Eveline Baumgart-Vogt; Ralph T Schermuly; Hossein A Ghofrani; Werner Seeger; Katrin Schröder; Friedrich Grimminger; Ralf P Brandes; Norbert Weissmann
Journal:  Nat Metab       Date:  2020-06-08

3.  Genome-Wide Transcriptional Analysis Reveals the Protection against Hypoxia-Induced Oxidative Injury in the Intestine of Tibetans via the Inhibition of GRB2/EGFR/PTPN11 Pathways.

Authors:  Kang Li; Luobu Gesang; Zeng Dan; Lamu Gusang
Journal:  Oxid Med Cell Longev       Date:  2016-08-09       Impact factor: 6.543

4.  Grb2 carboxyl-terminal SH3 domain can bivalently associate with two ligands, in an SH3 dependent manner.

Authors:  Richa Arya; Rohit Singh Dangi; Pinakin K Makwana; Ambrish Kumar; Santosh Kumar Upadhyay; Monica Sundd
Journal:  Sci Rep       Date:  2017-04-28       Impact factor: 4.379

5.  Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.

Authors:  Suji Han; Hyemi Shin; Jin-Ku Lee; Zhaoqi Liu; Raul Rabadan; Jeongwu Lee; Jihye Shin; Cheolju Lee; Heekyoung Yang; Donggeon Kim; Sung Heon Kim; Jooyeon Kim; Jeong-Woo Oh; Doo-Sik Kong; Jung-Il Lee; Ho Jun Seol; Jung Won Choi; Hyun Ju Kang; Do-Hyun Nam
Journal:  Exp Mol Med       Date:  2019-12-06       Impact factor: 8.718

Review 6.  Function of NADPH Oxidases in Diabetic Nephropathy and Development of Nox Inhibitors.

Authors:  Sae Rom Lee; Eun Jung An; Jaesang Kim; Yun Soo Bae
Journal:  Biomol Ther (Seoul)       Date:  2020-01-01       Impact factor: 4.634

7.  The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.

Authors:  Yuyan Dong; Juxiang Liu; Jing Ma; Jinxing Quan; Yanxia Bao; Yaqiang Cui
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

8.  NoxO1 Controls Proliferation of Colon Epithelial Cells.

Authors:  Franziska Moll; Maria Walter; Flávia Rezende; Valeska Helfinger; Estefania Vasconez; Tiago De Oliveira; Florian R Greten; Catherine Olesch; Andreas Weigert; Heinfried H Radeke; Katrin Schröder
Journal:  Front Immunol       Date:  2018-05-08       Impact factor: 7.561

Review 9.  NADPH oxidases: Current aspects and tools.

Authors:  Katrin Schröder
Journal:  Redox Biol       Date:  2020-05-23       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.